Abstract
Background: Skin fibrosis is a hallmark of systemic sclerosis (SSc). There are no widely accepted biomarkers of skin involvement in this condition. Several serum or plasma markers have been studied in patients with SSc - monocyte chemoattractant protein-1 (MCP-1), chemokine (C-X-C motif) ligand 8 (CXCL8), interleukin-13 (IL-13), and some more recognized such as - platelet derived growth factor (PDGF), transforming growth factor-beta 1 (TGF-beta 1), epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF). Objectives: The aim of this study was to assess several circulating biomarkers which may be relevant to the fibrosing process and further to correlate the obtained data with clinical indicators specific for SSc skin involvement. Methods: 59 SSc patients (M/F 9/50; mean age 52.1 years, mean disease duration 6.7 years, 36 patients with limited cutaneous SSc and 23 with diffuse cutaneous SSc. As a control group 36 healthy individuals matched to sex and age were examined. Serum concentrations of bFGF, granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage-colony stimulating factor (GM-CSF), MCP-1, PDGF, IL-8 and 13 were analysed using commercial multiplex kit. The following clinical examinations were performed: modified Rodnan skin score (mRSS), Hand Mobility in Scleroderma Test (assessing hand function) (HAMIS), Cochin Hand Function Scale (hand function) (CHFS), Delta Finger-to-Palm Distance (extension-flexion) (dFTP), inter-lip Distance (inter-lip), inter-incisor Distance (inter-incisor), and Mouth Handicap in Systemic Sclerosis Scale (mouth opening) (MHISS). For statistical evaluation Spearman’s correlation coefficient was used. Results: When compared with healthy controls serum concentrations of bFGF (p Conclusion: Our results have shown that G-CSF, GM-CSF and IL-8 play a substantial role in SSc fibrosing process. Potential biomarkers as bFGF, G-CSF, MCP-1 and IL-8 correlated with a few clinical indices of SSc skin involvement.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
